Login / Signup

Digital pathology for nonalcoholic steatohepatitis assessment.

Arun J SanyalPrakash JhaDavid E Kleiner
Published in: Nature reviews. Gastroenterology & hepatology (2023)
Histological assessment of nonalcoholic fatty liver disease (NAFLD) has anchored knowledge development about the phenotypes of the condition, their natural history and their clinical course. This fact has led to the use of histological assessment as a reference standard for the evaluation of efficacy of drug interventions for nonalcoholic steatohepatitis (NASH) - the more histologically active form of NAFLD. However, certain limitations of conventional histological assessment systems pose challenges in drug development. These limitations have spurred intense scientific and commercial development of machine learning and digital approaches towards the assessment of liver histology in patients with NAFLD. This research field remains an area in rapid evolution. In this Perspective article, we summarize the current conventional assessment of NASH and its limitations, the use of specific digital approaches for histological assessment, and their application to the study of NASH and its response to therapy. Although this is not a comprehensive review, the leading tools currently used to assess therapeutic efficacy in drug development are specifically discussed. The potential translation of these approaches to support routine clinical assessment of NAFLD and an agenda for future research are also discussed.
Keyphrases
  • machine learning
  • healthcare
  • stem cells
  • public health
  • mesenchymal stem cells
  • risk assessment
  • climate change
  • clinical practice
  • big data
  • current status
  • human health
  • light emitting